89 related articles for article (PubMed ID: 28601833)
1. In
Ouranos K; Mylonakis E
Ann Intern Med; 2024 May; 177(5):JC52. PubMed ID: 38710092
[TBL] [Abstract][Full Text] [Related]
2. Multicentre randomised controlled trial to investigate usefulness of the rapid diagnostic βLACTA test performed directly on bacterial cell pellets from respiratory, urinary or blood samples for the early de-escalation of carbapenems in septic intensive care unit patients: the BLUE-CarbA protocol.
Garnier M; Gallah S; Vimont S; Benzerara Y; Labbe V; Constant AL; Siami S; Guerot E; Compain F; Mainardi JL; Montil M; Quesnel C;
BMJ Open; 2019 Feb; 9(2):e024561. PubMed ID: 30782909
[TBL] [Abstract][Full Text] [Related]
3. Empirical antibiotic therapy modalities for Enterobacteriaceae bloodstream infections in older patients and their impact on mortality: a multicentre retrospective study.
Roseau-Vincenti A; Forestier E; Lanoix JP; Ricard C; Carret MC; Caraux-Paz P; Paccalin M; Gavazzi G; Roubaud-Baudron C;
Infection; 2024 Feb; 52(1):155-163. PubMed ID: 37608043
[TBL] [Abstract][Full Text] [Related]
4. An agent-based model on antimicrobial de-escalation in intensive care units: Implications on clinical trial design.
Huo X; Liu P
PLoS One; 2024; 19(4):e0301944. PubMed ID: 38626111
[TBL] [Abstract][Full Text] [Related]
5. Simplified Spectrum Score (S
de Lorenzi-Tognon M; Schrenzel J
Sci Rep; 2024 Apr; 14(1):9776. PubMed ID: 38684841
[TBL] [Abstract][Full Text] [Related]
6. Description and validation of a spectrum score method to measure antimicrobial de-escalation in healthcare associated pneumonia from electronic medical records data.
Madaras-Kelly K; Jones M; Remington R; Caplinger C; Huttner B; Samore M
BMC Infect Dis; 2015 Apr; 15():197. PubMed ID: 25927970
[TBL] [Abstract][Full Text] [Related]
7. An essential component of antimicrobial stewardship during the COVID-19 pandemic in the intensive care unit: de-escalation.
Pehlivanli A; Ozgun C; Sasal-Solmaz FG; Yuksel D; Basgut B; Ozcelikay AT; Unal MN
Eur J Hosp Pharm; 2024 May; ():. PubMed ID: 38749666
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial De-Escalation in Critically Ill Patients.
Tanzarella ES; Cutuli SL; Lombardi G; Cammarota F; Caroli A; Franchini E; Sancho Ferrando E; Grieco DL; Antonelli M; De Pascale G
Antibiotics (Basel); 2024 Apr; 13(4):. PubMed ID: 38667051
[TBL] [Abstract][Full Text] [Related]
9. Statistical analysis plan for the BLING III study: a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis.
Billot L; Lipman J; Brett SJ; De Waele JJ; Cotta MO; Davis JS; Finfer S; Hammond NE; Knowles S; McGuinness S; Myburgh J; Paterson DL; Peake S; Rajbhandari D; Rhodes A; Roberts JA; Roger C; Shirwadkar C; Starr T; Taylor C; Dulhunty JM;
Crit Care Resusc; 2021 Sep; 23(3):273-284. PubMed ID: 38046078
[No Abstract] [Full Text] [Related]
10. Impact of a syndrome-based stewardship intervention on antipseudomonal beta-lactam use, antimicrobial resistance,
Mena Lora AJ; Burgos R; Hunt AE; Wang Y; Huber D; Sanchez L; Ali M; Krill C; Takhsh E; Bleasdale SC
Antimicrob Steward Healthc Epidemiol; 2024; 4(1):e31. PubMed ID: 38500719
[TBL] [Abstract][Full Text] [Related]
11. Missed Opportunities: Intravenous versus Oral Antibiotic De-escalation for Treatment of Lower Extremity Osteoarticular Infections.
Ruan H; Ryan K; Sosa N; Walraven C
J Clin Pharmacol; 2024 Jan; 64(1):137-138. PubMed ID: 37656053
[No Abstract] [Full Text] [Related]
12. Rising to the De-escalation Challenge: Multilevel Change Needed to Align Clinical Practice with Cancer Screening Guidelines.
Schapira MM; Rendle KA
Med Decis Making; 2022 Nov; 42(8):1045-1047. PubMed ID: 36255190
[No Abstract] [Full Text] [Related]
13. Overtreatment of multiple myeloma and its precursor states: de-escalation is an urgent need in clinical practice and trials.
Mohyuddin GR; Goodman AM
Nat Rev Clin Oncol; 2024 Apr; ():. PubMed ID: 38649423
[No Abstract] [Full Text] [Related]
14. Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP).
Tabah A; Bassetti M; Kollef MH; Zahar JR; Paiva JA; Timsit JF; Roberts JA; Schouten J; Giamarellou H; Rello J; De Waele J; Shorr AF; Leone M; Poulakou G; Depuydt P; Garnacho-Montero J
Intensive Care Med; 2020 Feb; 46(2):245-265. PubMed ID: 31781835
[TBL] [Abstract][Full Text] [Related]
15. Targeted simplification versus antipseudomonal broad-spectrum beta-lactams in patients with bloodstream infections due to
López-Cortés LE; Rosso-Fernández C; Núñez-Núñez M; Lavín-Alconero L; Bravo-Ferrer J; Barriga Á; Delgado M; Lupión C; Retamar P; Rodríguez-Baño J;
BMJ Open; 2017 Jun; 7(6):e015439. PubMed ID: 28601833
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of a structured de-escalation from antipseudomonal β-lactams in bloodstream infections due to Enterobacterales (SIMPLIFY): an open-label, multicentre, randomised trial.
López-Cortés LE; Delgado-Valverde M; Moreno-Mellado E; Goikoetxea Aguirre J; Guio Carrión L; Blanco Vidal MJ; López Soria LM; Pérez-Rodríguez MT; Martínez Lamas L; Arnaiz de Las Revillas F; Armiñanzas C; Ruiz de Alegría-Puig C; Jiménez Aguilar P; Del Carmen Martínez-Rubio M; Sáez-Bejar C; de Las Cuevas C; Martín-Aspas A; Galán F; Yuste JR; Leiva-León J; Bou G; Capón González P; Boix-Palop L; Xercavins-Valls M; Goenaga-Sánchez MÁ; Anza DV; Castón JJ; Rufián MR; Merino E; Rodríguez JC; Loeches B; Cuervo G; Guerra Laso JM; Plata A; Pérez Cortés S; López Mato P; Sierra Monzón JL; Rosso-Fernández C; Bravo-Ferrer JM; Retamar-Gentil P; Rodríguez-Baño J;
Lancet Infect Dis; 2024 Apr; 24(4):375-385. PubMed ID: 38215770
[TBL] [Abstract][Full Text] [Related]
17. Role of Early De-escalation of Antimicrobial Therapy on Risk of Clostridioides difficile Infection Following Enterobacteriaceae Bloodstream Infections.
Seddon MM; Bookstaver PB; Justo JA; Kohn J; Rac H; Haggard E; Mediwala KN; Dash S; Al-Hasan MN
Clin Infect Dis; 2019 Jul; 69(3):414-420. PubMed ID: 30312362
[TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy of β-lactam/β-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum β-lactamase-producing Enterobacteriaceae in haematological patients with neutropaenia: a study protocol for a retrospective observational study (BICAR).
Gudiol C; Royo-Cebrecos C; Tebe C; Abdala E; Akova M; Álvarez R; Maestro-de la Calle G; Cano A; Cervera C; Clemente WT; Martín-Dávila P; Freifeld A; Gómez L; Gottlieb T; Gurguí M; Herrera F; Manzur A; Maschmeyer G; Meije Y; Montejo M; Peghin M; Rodríguez-Baño J; Ruiz-Camps I; Sukiennik TC; Carratalà J;
BMJ Open; 2017 Jan; 7(1):e013268. PubMed ID: 28115333
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
